Fusion partner cells and uses thereof

Details Fusion partner cells and uses thereof Fusion partner cells and uses thereof

2002-12-18

2009-02-17

Canella, Karen A (Department: 1643)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S355000, C435S372100, C435S372200, C435S374000, C435S375000

Reexamination Certificate

active

07491530

ABSTRACT:
The present invention provides in one aspect novel fusion partner cells that ectopically express one or more genes that alter the phenotype of a hybrid cell made from a fusion of the fusion partner cell and a fusion cell, hybrid cell lines produced using the fusion partner cells. The invention in another aspect provides antibodies produced by certain hybrid cell lines, and compositions containing one or a combination of such antibodies or antigen-binding fragments thereof. The invention also provides in another aspect methods of using the antibodies or antigen-binding fragments thereof for diagnosis and treatment of diseases characterized by the antigens specifically bound by the antibodies.

REFERENCES:
patent: 5686306 (1997-11-01), West et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 5998209 (1999-12-01), Jokobovits et al.
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6091001 (2000-07-01), Jakobovits et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6130364 (2000-10-01), Jakobovits et al.
patent: 6150584 (2000-11-01), Kucherlapati et al.
patent: 6162963 (2000-12-01), Kucherlapati et al.
patent: 6207418 (2001-03-01), Hori et al.
patent: 6235883 (2001-05-01), Jakobovits et al.
patent: 2002/0045219 (2002-04-01), Dessain et al.
patent: WO 02/04607 (2002-01-01), None
patent: WO 02/010352 (2002-02-01), None
patent: WO 02/10352 (2002-02-01), None
patent: WO 03/052082 (2003-06-01), None
Chen et al. Unveiling the mechanisms of cell-cell fusion. Science 308: 369-373, 2005.
Nelson et al. Monoclonal antibodies. J. Clin. Path: Mol. Pathol. 53:111-117, 2000.
Ehlers et al. Combining two mutations of human interleukin-6 that affect gp130 activation results in a potent interleukin-6 receptor antagonist on human myeloma cells. Journal of Biological Chemistry 270(14): 8185-8163, 1995.
Devroe et al. Retrovirus-delivered siRNA. BMC Biotechnology 2:15, available from http://www.biomedcentral.com/1472-6750/2/15. Aug. 2002.
Harris et al. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6. J. Immunological Methods 148: 199-207, 1992.
Sontag et al. The interaction of SC40 small tumor antigen with protein phosphatase 2A stimulates the Map Kinase pathway and induces cell proliferation. Cell 75: 887-897, 1993.
Yin et al. Involvement of IL-6 signal transducer gp130 in IL-11 mediated signal transduction. J. Immunology 151(5):2555-2561, 1993.
Abstract of Nho et al (Blood, 2000, vol. 96, p. 752a).
Carroll, W.L. et al., Mouse × human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods. May 1, 1986;89(1):61-72.
Dessain, S.K. et al., High efficiency creation of human monoclonal antibody-producing hybridomas. J Immunol Methods. Aug. 2004;291(1-2):109-22.
Larrick, J.W. et al., Characterization of human hybridomas secreting antibody to tetanus toxoid. Proc Natl Acad Sci U S A. Oct. 1983;80(20):6376-80.
Ajiro, K. et al., Species-Specific Suppression of Histone H1 and H2B Production in Human/Mouse Hybrids,Proc. Natl. Acad. Sci. USA75:5599-5603, 1978.
Borth, N. et al., Analysis of Changes During Subclone Development and Ageing of Human Antibody-Producing Heterohybridoma Cells By Northern Blot and Flow Cytometry,J. Biotechnol.67:57-66, 1999.
Cieplinski, W. et al., Non-Random Human Chromosome Distribution in Human-Mouse Myeloma Somatic Cell Hybrids,Cytogenet.Cell Genet.35:93-99, 1983.
Croce, C.M. et al., Unidirectional Loss of Human Chromosomes in Rat-Human Hybrids,Exp. Cell Res.79:461-463, 1973.
Glasky, M.S. et al., Stability of Specific Immunoglobulin Secretion by EBV-Transformed Lymphoblastoid Cells and Human-Murine Heterohybridomas,Hybridoma8:377-389, 1989.
Goss, S.J. et al., New Method for Mapping Genes in Human Chromosomes,Nature255:680-684, 1975.
Groves, D.J. et al., Veterinary Sources of Nonrodent Monoclonal Antibodies: Interspecific and Intraspecific Hybridomas,Hybridoma19:201-214, 2000.
Handmaker, SD, Chromosome Behaviour in Human-Mouse Somatic-Cell Hybrids,Biochem. J.124:37P, 1971.
Harris, J.F. et al., Spontaneous and Radiation-Induced genetic Instability of Heteromyeloma Hybridoma Cells,Mol. Biol. Med.7:485-493, 1990.
Huebner, K. et al., Suppression of Replication of SV40 and Polyoma Virus in Mouse-Human Hybrids,Cell11:25-33, 1977.
Jessup, C.F. et al., Preparation of Human-Mouse Heterohybridomas Against an Immunising Antigen,J. Immunol. Methods246:187-202, 2000.
Kawano, M. et al., Autocrine Generation and Requirement of BSF-2/IL-6 For Human Multiple Myelomas,Nature332:83-85, 1988.
Miggiano, V. et al., Hybrids Between Human Leukocytes and a Mouse Cell Line: Production and Characterization,Wistar Inst Symp Monogr9:61-76, 1969.
Nabholz, M et al., Genetic Analysis With Human-Mouse Somatic Cell Hybrids,Nature223:358-363, 1969.
Norum, R.A. et al., Non-Random Loss of Human Markers from Man-Mouse Somatic Cell Hybrids,Nature251:72-74, 1974.
Raison, R.L. et al., Loss of Secretion in Mouse-Human Hybrids Need Not Be Due to the Loss of a Structural Gene,J. Exp. Med.156:1380-1389, 1982.
Rushton, A.R., Quantitative Analysis of Human Chromosome Segregation in Man-Mouse Somatic Cell Hybrids,Cytogenet. Cell Genet.17:243-253, 1976.
Van Snick, J., Interleukin-6: An Overview,Annu. Rev. Immunol.8:253-278, 1990.
Guo, Y. et al., Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B Cells.Science, 263:518-520, 1994.
Berube, N. et al., The Genetics of Cellular Scenescence,Am. J. Hum. Genet. 62:000 (1998).
Borrebaeck, C. et al, Does Endogenous Glycosylation Prevent the Use of Mouse Monoclonal Antibodies as Cancer Therapeutics?,Immun. Today14(10):477 (1993).
Borth, N. et al., Analysis of changes during subclone development and ageing of human antibody-producing heterohybridoma cells by Northern blot and flow cytometry,J. Biotech.67:57 (1999).
Burk, K. et al., Establishment of a Human Plasma Cell Line in Vitro,Cancer Research38:2503 (1978).
Chiorazzi, N. et al., Use of Epstein-Barr Virus-Transformed B Cell Lines for the Generation of Immunoglobulin-Producing Human B Cell Hybridomas,J. Exp. Med.156:930 (1982).
Cote, R., et al., Generation of Human Monoclonal Antibodies Reactive with Cellular Antigens,Proc. Natl. Acad. Sci. USA80(7):2026 (1983) (Abstract Only).
Croce, et al., Production of Human Hybridomas Secreting Antibodies to Measles Virus,Nature288:4 (1980).
Drexler, H. et al., False Human Hematopoietic Cell Lines: Cross Contaminations and Misinterpretations,Leukemia13(10):1601 (1999) (Abstract Only).
Ebeling, S. et al., Human Chromosome 21 Determines Growth Factor Dependence in Human/Mouse B-Cell Hybridomas,Cancer Res.58:2863 (1998).
Edwards, P. et al., A Human-Human Hybridoma System Based on a Fast-Growing Mutant of the ARH-77 Plasma Cell Leukemia-Derived Line,Eur. J. Immunol.12:641 (1982).
Gooding, R. et al., Phenotypic and Molecular Analysis of Six Human Cell Lines Derived From Patients with Plasma Cell Dyscrasia,Br. J. Haemotology106:669 (1999).
Harris, H. et al., Mitosis in Hybrid Cells Derived From Mouse and Man,Nature207:606 (1965).
Harris, J. et al., Increased Frequency of Both Total and Specific Monoclonal Antibody Producing Hybridomas Using a Fusion Partner That Constitutively Expresses Recombinant IL-6,J. Immunol. Methods148:199 (1992).
Harris, N. et al., Plasma Cell Surface Antigen on Human Blood Lymphocytes,Nature250:507 (1974).
Hirano, T. et al. Complementary DNA for a Novel Human Interleukin (BSF-2) that Induces B Lymphocytes to Produce Immunoglobulin,Nature324:73 (1986).
Jessup, C. et al., Preparation of Human-Mouse Heterohybridomas Against an Immunising Antigen,J. Immunol. Methods246:187 (2000).
Karpas, A. et al., A Human Myeloma Cell Line Suitable for the Generation of Human Monoclonal Antibodies,PNAS98(4):1799 (2001).
Kayhty, H. et al., Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine is Immunogenic in Infants and Chrildren,J. Infectious Disease172:1273 (1995).
Koropatnick, J.

Affiliated with

Also associated with

Rating

Fusion partner cells and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fusion partner cells and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion partner cells and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4137258